Printer's No. PN3419
See other bills
under the
same topic PRINTER'S NO. 3419 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.529 Session of 2026 INTRODUCED BY RAPP, VENKAT, KAUFFMAN, PICKETT, RIVERA AND GALLAGHER, MAY 14, 2026 REFERRED TO COMMITTEE ON HEALTH, MAY 20, 2026 A RESOLUTIONDesignating the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.WHEREAS, Idiopathic pulmonary fibrosis is a debilitating and generally fatal disease marked by progressive scarring of the lungs, causing an irreversible loss of the lung tissue's ability to transport oxygen; andWHEREAS, Idiopathic pulmonary fibrosis progresses quickly, often causing disability or death within three to five years; andWHEREAS, Idiopathic pulmonary fibrosis is the most common form of interstitial lung disease; andWHEREAS, There is no proven cause of idiopathic pulmonary fibrosis, and it is often misdiagnosed or underdiagnosed; andWHEREAS, Idiopathic pulmonary fibrosis is five times more common than cystic fibrosis and Lou Gehrig's disease, yet the disease remains virtually unknown and receives a fraction of the 12345678910111213141516171819 research funding; andWHEREAS, It is estimated that idiopathic pulmonary fibrosis affects between 132,000 to 200,000 individuals in the United States and more than 48,000 new cases are diagnosed each year; andWHEREAS, Approximately 40,000 people die each year due to idiopathic pulmonary fibrosis, which is similar to the number of deaths that occur due to breast cancer; andWHEREAS, Approximately 7,000 Pennsylvanians suffer from idiopathic pulmonary fibrosis; andWHEREAS, This Commonwealth has become a leader in the research and treatment of idiopathic pulmonary fibrosis, with more than 15% of all lung transplants in the United States performed in Pennsylvania hospitals; andWHEREAS, Organizations like the Wescoe Foundation for Pulmonary Fibrosis play a crucial role in raising awareness and providing support and education for patients, families and health care providers throughout this Commonwealth; andWHEREAS, Increased research, awareness and detection of idiopathic pulmonary fibrosis is needed; therefore be itRESOLVED, That the House of Representatives designate the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.20260HR0529PN3419 - 2 - 12345678910111213141516171819202122232425
under the
same topic PRINTER'S NO. 3419 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.529 Session of 2026 INTRODUCED BY RAPP, VENKAT, KAUFFMAN, PICKETT, RIVERA AND GALLAGHER, MAY 14, 2026 REFERRED TO COMMITTEE ON HEALTH, MAY 20, 2026 A RESOLUTIONDesignating the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.WHEREAS, Idiopathic pulmonary fibrosis is a debilitating and generally fatal disease marked by progressive scarring of the lungs, causing an irreversible loss of the lung tissue's ability to transport oxygen; andWHEREAS, Idiopathic pulmonary fibrosis progresses quickly, often causing disability or death within three to five years; andWHEREAS, Idiopathic pulmonary fibrosis is the most common form of interstitial lung disease; andWHEREAS, There is no proven cause of idiopathic pulmonary fibrosis, and it is often misdiagnosed or underdiagnosed; andWHEREAS, Idiopathic pulmonary fibrosis is five times more common than cystic fibrosis and Lou Gehrig's disease, yet the disease remains virtually unknown and receives a fraction of the 12345678910111213141516171819 research funding; andWHEREAS, It is estimated that idiopathic pulmonary fibrosis affects between 132,000 to 200,000 individuals in the United States and more than 48,000 new cases are diagnosed each year; andWHEREAS, Approximately 40,000 people die each year due to idiopathic pulmonary fibrosis, which is similar to the number of deaths that occur due to breast cancer; andWHEREAS, Approximately 7,000 Pennsylvanians suffer from idiopathic pulmonary fibrosis; andWHEREAS, This Commonwealth has become a leader in the research and treatment of idiopathic pulmonary fibrosis, with more than 15% of all lung transplants in the United States performed in Pennsylvania hospitals; andWHEREAS, Organizations like the Wescoe Foundation for Pulmonary Fibrosis play a crucial role in raising awareness and providing support and education for patients, families and health care providers throughout this Commonwealth; andWHEREAS, Increased research, awareness and detection of idiopathic pulmonary fibrosis is needed; therefore be itRESOLVED, That the House of Representatives designate the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.20260HR0529PN3419 - 2 - 12345678910111213141516171819202122232425
Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.